© American Cancer Society
Does one size fit all? The updated ovarian cancer staging: Still a work in progress
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Ovarian cancer treatment: The end of empiricism?
Immunotherapy in acute myeloid leukemia
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases
Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry
Recently Published Issues
Increased Impact factor for 2014 is 5.068!
From Dr. Khuri
In this editorial, Editor-in-Chief Dr. Fadlo R. Khuri and Chest and Lung Disease Section Editor Dr. Suresh S. Ramalingam explain why Cancer will no longer consider any work that is funded directly or indirectly from tobacco companies or their subsidiaries.
Read the editorial here: